BMRN earnings date and history (2026)
BioMarin Pharmaceutical Inc. (BMRN) has no scheduled report date on the calendar yet. Its last report, on Mon Nov 2, came in at $0.02 against a -$0.30 consensus; the stock moved -3.1% on the news. Not investment advice.
See every company reporting on the earnings calendar or the filed financial statements.
Past reports#
Data provided bySource: Twelve DataNewest first. The surprise is the reported EPS against the consensus going in, in percent; the move is the stock’s close-to-close change over the first session that could trade on the report, shown once that session has settled and only where the report’s timing is established — the earnings calendar, the time the company filed its earnings release with the SEC and the day’s trading volume, by majority.
| Date | Est | Actual | Move |
|---|---|---|---|
| Nov 2, 2026 | -$0.30 | $0.02 | -3.1% |
| Oct 26, 2026 | -$0.30 | -$0.08 | — |
| Aug 6, 2026 | $0.79 | $0.90 | +3.8% |
| May 4, 2026 | $0.78 | $0.58 | -4.0% |
| Feb 23, 2026 | $0.07 | $0.28 | -0.5% |
| Oct 27, 2025 | $0.82 | -$0.08 | +1.6% |
| Aug 4, 2025 | $0.80 | $1.25 | +2.7% |
| May 1, 2025 | $0.73 | $0.98 | -1.1% |
| Feb 19, 2025 | $0.55 | $0.72 | +4.8% |
| Oct 29, 2024 | $0.57 | $0.74 | -4.6% |
| Aug 5, 2024 | $0.38 | $0.77 | +8.0% |
| Apr 24, 2024 | $0.37 | $0.49 | -9.9% |
| Feb 22, 2024 | $0.24 | $0.26 | +1.4% |
| Nov 1, 2023 | $0.28 | $0.26 | -5.2% |
| Jul 31, 2023 | $0.24 | $0.34 | +1.2% |
| Apr 26, 2023 | $0.24 | $0.39 | -0.6% |
| Feb 27, 2023 | $0.12 | $0.11 | -3.5% |
| Oct 26, 2022 | $0.12 | $0.16 | -6.9% |
| Aug 3, 2022 | $0.20 | $0.33 | +5.2% |
| Apr 27, 2022 | $0.15 | $0.31 | +2.9% |
| Feb 23, 2022 | -$0.22 | -$0.21 | -6.3% |
| Oct 27, 2021 | -$0.12 | -$0.03 | +9.0% |
| Jul 28, 2021 | $0.05 | $0.23 | -0.3% |
About this data#
Report dates, sessions, consensus EPS estimates, reported EPS and surprises are third-party figures, subject to change, and may not be accurate. A quarter whose session is known is shown with it; for one whose session is not, the move is left blank rather than guessed, because a pre-open and an after-close report trade on different sessions. The move is ChartRow's own: the first settled close that could trade on the report over the close before it, price return. Not investment advice.
FAQ#
- Did BMRN beat earnings last quarter?
- Yes: on Mon Nov 2 BMRN reported $0.02 against a -$0.30 consensus, a +106.7% surprise.
- How did BMRN stock react to its last earnings?
- BMRN moved -3.1% on its last earnings report. It reported on Mon Nov 2, 2026, after the close, so the first trading session that could react was Tue Nov 3. BMRN closed at $57.44 on Mon Nov 2 and at $55.66 on Tue Nov 3, and $55.66 ÷ $57.44 − 1 = -3.1%. Both are ChartRow's own settled closing prices.
